APC guidance has been grouped according to BNF chapter.
Guidance includes
– Shared care guidance
– Clinical guidelines
– Information sheets – to help ongoing care in primary care following specialist initiation/recommendation.

Gastro-Intestinal System

NENC LFT Guidelines NENC Hepatology Network V2.2 May 2021 Final
Bariatric surgery – management of patients, post-bariatric surgery, in primary care June 2021
Prescribing Trans Anal Irrigation – guidelines for prescribing 2019 v2.0

Cardiovascular System
Amiodarone SCG v1.1
Angina GL (Updated 2014)
Atrial fibrillation – Prescribing for Non-valvular AF in Primary Care v2.0
Dronedarone SCG – Sept 17
Northern England Evaluation and Lipid Intensification NEELI Clinical Guidelines (replaces FATS7)
Top Tips and Recommendations for Sodium Glucose Co-transporter 2 inhibitors (SGLT2i) in HFrEF; NTAG June 2022 
NENC Patient Specific Factors to Consider When Choosing a DOAC in NVAF; NTAG June 2022

Respiratory System
COPD management guidelines v2.0

Central Nervous system
Agomelatine – Primary Care Information Sheet v1.0
Cognitive enhancing medication – leaflet for primary care v2.0
Adult ADHD Shared Care – March 2021
Children’s ADHD Shared care June 2021
Antipsychotic Leaflet update – August 2022
Dexamfetamine for Narcolepsy SCG v1.0
APC position statement non-palliative care use of opiates
Sativex SCG Feb 2022
Apomorphine shared care agreement V1.0

Regional Headache Guideline March 2022
Ketamine-in-Palliative-Care-pain-2020 v1.0
Lithium – shared care NoTGNC June 2022
Methylphenidate secondary to brain injury Sept 21
Melatonin – Shared Care June 2021
Melatonin Deprescribing Guideline March 2022
Vigabatrin SCG – Jul 2014

Infections and antibiotics
NICE/PHE antimicrobial guidance: summary
Nebulised – Gentamicin Information-for-Primary-Care v2.0

Endocrine System
Denosumab information sheet – Dec 2021
Thyroid Gudelines (TRAMP2) June 2018
Osteoporosis (ext June 2022)
Gender Dyphoria Hormone Guidance August 22 V2
Menopause guidance June 2022

NICE Diabetes Guidance visual-summary-March 2022
Top Tips and Recommendations for use of Sodium Glucose Co-transporter 2 inhibitors (SGLT2i) in people with Type 2 Diabetes (T2DM) For Glycaemic Control: NTAG June 2022  

Genito-Urinary System
Erectile Dysfunction Guidelines for the investigation and management of men with ED Updated August 2022
Non Surgical Management of Overactive Bladder (OAB) Pathway February 2021
Urology Guidelines – March 22
Methylphenidate for giggle incontinence – Children – July 2018
Catheter Formulary and Guidance Sept 2021
Catheter info sheet v1.0
Urinary Continence Enablement Products and Devices Formulary 2021

Renal Disease
Top Tips and Recommendations for Dapagliflozin [FORXIGA] in Chronic Kidney Disease (CKD) ; NTAG June 2022
Renal Patients – Symptom Management v1.0

Malignant Disease and Immunosuppression
NoT G Monitoring of IMDs Updated Sept 2022
Hydroxychloroquine Shared care guidance v.5 Oct 2022 Final
Immunosuppressive-treatment-following-liver-transplants-SCG June 21
Lanreotide and Octreotide July 2019 v2.0
Immunosuppressive-Treatment-for-Paediatric-Nephrotic-Syndrome-SCG July 2020 v1.0
Tocilizumab-monitoring-shared-care-guidance-June-18 v1
NECN Palliative and End of life Symptom Control Guidelines 2021 (Fifth edition)

Immunosuppression following adult renal transplant
Azathioprine shared care agreement 2021 final
Ciclosporin shared care agreement 2021 final
MMF mycophenolic acid shared care agreement 2021 final
Prednisolone shared care agreement 2021 final
Sirolimus shared care agreement 2021 final
Tacrolimus shared care agreement 2021 final
Immunosuppression following Paediatric renal transplantation SCG – Oct 17

Nutrition and Blood
Erythropoietin (Darbepoetin [Aranesp]) in the Treatment of Patients with CKD – Jul 17
Cinacalcet in primary hyperparathyroidism – 2020 final V4
Cows-milk-allergy-and-lactose-intolerance-guidance-January-2021 V3
Vitamin D Quick reference guide v3.0
Gluten free guidelines Updated Nov 2022
Oral Nutritional Support guidance and formulary FINAL v1.0 Jan 2021
Preterm Infant feeding prescribing guideline 2021-final
Faltering Growth February 2021 final

Musculoskeletal and Joint Diseases

Ear, Eyes, Nose and Throat
ENT Guideline – Feb 2017
Eye conditions – NoT & G Guidelines for the management of common Opthalmology Conditions – Sep 2016

Acne management Guidelines v2.1

Other Guidance
Prescribing Intervals Guidance July 2021
Seven-day-Rx-and-MCAs v2.4
Stoma-Prescribing-Guidelines Sept 2020
Swallowing-difficulties v2.0
Third party ordering – January 2019 (expiry date extension)